Outpatient anticoagulant therapy may cut COVID-19 admission risk

Toxic fatty acids to blame for brain cell death after injury
6 October 2021
Polio leaves Ukraine toddler paralysed: ministry
6 October 2021

Outpatient anticoagulant therapy may cut COVID-19 admission risk

(HealthDay)—Individuals using anticoagulation therapy on an outpatient basis who are diagnosed with COVID-19 have a reduced risk for hospital admission, according to a study published online Sept. 24 in EClinicalMedicine.

Comments are closed.